Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
Más filtros











Intervalo de año de publicación
1.
Mol Biol Rep ; 51(1): 767, 2024 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-38878205

RESUMEN

BACKGROUND: Esterases (EC 3.1.1.X) are enzymes that catalyze the hydrolysis ester bonds. These enzymes have large potential for diverse applications in fine industries, particularly in pharmaceuticals, cosmetics, and bioethanol production. METHODS AND RESULTS: In this study, a gene encoding an esterase from Thermobifida fusca YX (TfEst) was successfully cloned, and its product was overexpressed in Escherichia coli and purified using affinity chromatography. The TfEst kinetic assay revealed catalytic efficiencies of 0.58 s-1 mM-1, 1.09 s-1 mM-1, and 0.062 s-1 mM-1 against p-Nitrophenyl acetate, p-Nitrophenyl butyrate, and 1-naphthyl acetate substrates, respectively. Furthermore, TfEst also exhibited activity in a pH range from 6.0 to 10.0, with maximum activity at pH 8.0. The enzyme demonstrated a half-life of 20 min at 70 °C. Notably, TfEst displayed acetyl xylan esterase activity as evidenced by the acetylated xylan assay. The structural prediction of TfEst using AlphaFold indicated that has an α/ß-hydrolase fold, which is consistent with other esterases. CONCLUSIONS: The enzyme stability over a broad pH range and its activity at elevated temperatures make it an appealing candidate for industrial processes. Overall, TfEst emerges as a promising enzymatic tool with significant implications for the advancement of biotechnology and biofuels industries.


Asunto(s)
Acetilesterasa , Esterasas , Thermobifida , Acetilesterasa/metabolismo , Acetilesterasa/genética , Acetilesterasa/química , Concentración de Iones de Hidrógeno , Cinética , Especificidad por Sustrato , Thermobifida/enzimología , Thermobifida/genética , Esterasas/metabolismo , Esterasas/genética , Esterasas/química , Estabilidad de Enzimas , Temperatura , Escherichia coli/genética , Escherichia coli/metabolismo , Clonación Molecular/métodos , Hidrólisis , Xilanos/metabolismo , Butiratos/metabolismo , Proteínas Bacterianas/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/química , Nitrofenoles
2.
Microbiol Res ; 285: 127739, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38763016

RESUMEN

Clostridioides difficile may have a negative impact on gut microbiota composition in terms of diversity and abundance, thereby triggering functional changes supported by the differential presence of genes involved in significant metabolic pathways, such as short-chain fatty acids (SCFA). This work has evaluated shotgun metagenomics data regarding 48 samples from four groups classified according to diarrhea acquisition site (community- and healthcare facility-onset) and positive or negative Clostridioides difficile infection (CDI) result. The metagenomic-assembled genomes (MAGs) obtained from each sample were taxonomically assigned for preliminary comparative analysis concerning differences in composition among groups. The predicted genes involved in metabolism, transport, and signaling remained constant in microbiota members; characteristic patterns were observed in MAGs and genes involved in SCFA butyrate and acetate metabolic pathways for each study group. A decrease in genera and species, as well as relative MAG abundance with the presence of the acetate metabolism-related gene, was evident in the HCFO/- group. Increased antibiotic resistance markers (ARM) were observed in MAGs along with the genes involved in acetate metabolism. The results highlight the need to explore the role of acetate in greater depth as a potential protector of the imbalances produced by CDI, as occurs in other inflammatory intestinal diseases.


Asunto(s)
Acetatos , Clostridioides difficile , Infecciones por Clostridium , Microbioma Gastrointestinal , Metagenoma , Metagenómica , Clostridioides difficile/genética , Acetatos/metabolismo , Humanos , Infecciones por Clostridium/microbiología , Ácidos Grasos Volátiles/metabolismo , Genoma Bacteriano , Butiratos/metabolismo , Redes y Vías Metabólicas/genética , Heces/microbiología , Diarrea/microbiología
3.
Int J Mol Sci ; 25(9)2024 Apr 29.
Artículo en Inglés | MEDLINE | ID: mdl-38732048

RESUMEN

HIV infection results in marked alterations in the gut microbiota (GM), such as the loss of microbial diversity and different taxonomic and metabolic profiles. Despite antiretroviral therapy (ART) partially ablating gastrointestinal alterations, the taxonomic profile after successful new ART has shown wide variations. Our objective was to determine the GM composition and functions in people living with HIV (PLWHIV) under ART in comparison to seronegative controls (SC). Fecal samples from 21 subjects (treated with integrase strand-transfer inhibitors, INSTIs) and 18 SC were included. We employed 16S rRNA amplicon sequencing, coupled with PICRUSt2 and fecal short-chain fatty acid (SCFA) quantification by gas chromatography. The INSTI group showed a decreased α-diversity (p < 0.001) compared to the SC group, at the expense of increased amounts of Pseudomonadota (Proteobacteria), Segatella copri, Lactobacillus, and Gram-negative bacteria. Concurrently, we observed an enrichment in Megasphaera and Butyricicoccus, both SCFA-producing bacteria, and significant elevations in fecal butyrate in this group (p < 0.001). Interestingly, gut dysbiosis in PLWHIV was characterized by a proinflammatory environment orchestrated by Pseudomonadota and elevated levels of butyrate associated with bacterial metabolic pathways, as well as the evident presence of butyrogenic bacteria. The role of this unique GM in PLWHIV should be evaluated, as well as the use of butyrate-based supplements and ART regimens that contain succinate, such as tenofovir disoproxil succinate. This mixed profile is described for the first time in PLWHIV from Mexico.


Asunto(s)
Heces , Microbioma Gastrointestinal , Infecciones por VIH , ARN Ribosómico 16S , Humanos , Infecciones por VIH/microbiología , Infecciones por VIH/tratamiento farmacológico , México , Femenino , Masculino , Adulto , Persona de Mediana Edad , Heces/microbiología , ARN Ribosómico 16S/genética , Disbiosis/microbiología , Ácidos Grasos Volátiles/metabolismo , Ácidos Grasos Volátiles/análisis , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Butiratos/metabolismo
4.
Clinics (Sao Paulo) ; 78: 100303, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37931529

RESUMEN

OBJECTIVE: Immunotherapy has been proven to improve the prognosis of patients with advanced malignancy but has shown limited efficacy in patients with Colorectal Cancer (CRC). Increasing evidence suggests that butyrate, a bacterial metabolite, enhances the efficacy of cancer therapies by modulating immune responses. Here, the effect and the mechanism of butyrate on anti-PD-L1 therapy were investigated in CRC. METHODS: The expression of PD-L1 and STAT1, and the lysine acetylation of STAT1 in CRC cells were observed after treatment with butyrate (2, 5, and 10 mM) for 24h or butyrate (5 mM) for 8, 16, and 24h. Site-directed mutations of STAT1 (K410R or K413R) were introduced to determine the role of STAT1 acetylation in modulating PD-L1 expression. The effect of butyrate on the cytotoxicity of CD8+ T-cells against CRC cells with or without PD-L1 overexpression was explored in vitro and in vivo. RESULTS: Butyrate could suppress IFN-γ-induced PD-L1 up-regulation in CRC cells in a dose- and time-dependent way. Butyrate promoted the lysine acetylation of STAT1 to reduce STAT1 expression. Non-acetylated mutant STAT1 not only ameliorated butyrate-induced suppression of lysine acetylation and nuclear translocation of STAT1 but also blocked the effect of butyrate on PD-L1. Butyrate attenuated the IFN-γ-induced impairment of CD8+ T-cell cytotoxicity against CRC cells. Meanwhile, butyrate suppressed CRC tumor growth by enhancing CD8+ T-cell infiltration. However, directly overexpressing PD-L1 in CRC cells could abolish the effect of butyrate. CONCLUSION: Butyrate strengthens the immune response to CRC cells by suppressing PD-L1 expression via acetylation of STAT1.


Asunto(s)
Antígeno B7-H1 , Neoplasias Colorrectales , Humanos , Antígeno B7-H1/genética , Antígeno B7-H1/metabolismo , Butiratos/farmacología , Butiratos/metabolismo , Lisina/metabolismo , Linfocitos T CD8-positivos , Línea Celular Tumoral , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/genética , Factor de Transcripción STAT1/metabolismo
5.
Int J Mol Sci ; 23(3)2022 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-35163519

RESUMEN

Glucosinolate transporters (GTRs) are part of the nitrate/peptide transporter (NPF) family, members of which also transport specialized secondary metabolites as substrates. Glucosinolates are defense compounds derived from amino acids. We selected 4-methylthiobutyl (4MTB) and indol-3-ylmethyl (I3M) glucosinolates to study how GTR1 from Arabidopsis thaliana transports these substrates in computational simulation approaches. The designed pipeline reported here includes massive docking of 4MTB and I3M in an ensemble of GTR1 conformations (in both inward and outward conformations) extracted from molecular dynamics simulations, followed by clustered and substrate-protein interactions profiling. The identified key residues were mutated, and their role in substrate transport was tested. We were able to identify key residues that integrate a major binding site of these substrates, which is critical for transport activity. In silico approaches employed here represent a breakthrough in the plant transportomics field, as the identification of key residues usually takes a long time if performed from a purely wet-lab experimental perspective. The inclusion of structural bioinformatics in the analyses of plant transporters significantly speeds up the knowledge-gaining process and optimizes valuable time and resources.


Asunto(s)
Arabidopsis/metabolismo , Glucosinolatos/metabolismo , Proteínas de Transporte de Monosacáridos/química , Proteínas de Transporte de Monosacáridos/metabolismo , Proteínas de Arabidopsis/química , Proteínas de Arabidopsis/metabolismo , Transporte Biológico , Butiratos/metabolismo , Indoles/metabolismo , Modelos Moleculares , Simulación del Acoplamiento Molecular , Unión Proteica , Conformación Proteica , Tioglucósidos/metabolismo
6.
Carcinogenesis ; 42(8): 1026-1036, 2021 08 19.
Artículo en Inglés | MEDLINE | ID: mdl-33999989

RESUMEN

Hepatocellular carcinoma (HCC) presents with a high treatment resistance and poor prognosis. Early diagnosis and preventive approaches such as chemoprevention are essential for the HCC control. Therefore, we evaluated the chemopreventive effects of butyrate-containing structured lipids (STLs) administered during the promotion stage of hepatocarcinogenesis in rats submitted to the 'resistant hepatocyte' (RH) model. Administration of butyrate-containing STLs inhibited the incidence and mean number of visible hepatic nodules per rat and reduced the number and area of glutathione S-transferase placental form-positive (GST-P+) preneoplastic focal lesions in the livers. This was accompanied by the induction of apoptosis and an increased level of hepatic butyric acid. Treatment with butyrate-containing STLs resulted in increased histone H3 lysine 9 (H3K9) acetylation, reduction of total histone deacetylase (HDAC) activity, and lower levels of HDAC4 and HDAC6 proteins. The chemopreventive effect of butyrate-containing STLs was also associated with the increased nuclear compartmentalization of p53 protein and reduced expression of the Bcl-2 protein. In addition, rats treated with butyrate-containing STLs showed decreased DNA damage and telomerase activity in the livers. These results demonstrate that the suppressive activity of butyrate-containing STLs is associated with inhibition of elevated during hepatocarcinogenesis chromatin-modifying proteins HDAC4 and HDAC6, subcellular redistribution of the p53 protein, and decreased DNA damage and telomerase activity.


Asunto(s)
Butiratos/metabolismo , Daño del ADN , Gutatión-S-Transferasa pi/metabolismo , Histona Desacetilasa 6/metabolismo , Histona Desacetilasas/metabolismo , Lípidos/química , Neoplasias Hepáticas Experimentales/patología , Telomerasa/metabolismo , Animales , Carcinogénesis , Caspasa 3/metabolismo , Neoplasias Hepáticas Experimentales/enzimología , Neoplasias Hepáticas Experimentales/genética , Masculino , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ratas , Ratas Wistar , Fracciones Subcelulares/enzimología , Proteína p53 Supresora de Tumor/metabolismo , Ácido alfa-Linolénico/metabolismo
7.
Arch Anim Nutr ; 75(1): 48-63, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33475008

RESUMEN

This research aimed to evaluate the apparent total tract digestibility (ATTD) of nutrients, metabolisable energy (ME) and palatability of the diet, as well as products of intestinal fermentation and faecal microbiota of dogs fed with dried apple. For this purpose, three experiments were performed. In Experiment I, digestibility and ME of four diets containing 0%, 3%, 6% and 9% dried apple were evaluated, in addition to the faecal characteristics of the dogs. The diets were offered to eight adult dogs, distributed in double Latin square (4 × 4), totalling eight repetitions per treatment. In Experiment II, products of intestinal fermentation and faecal microbiota from 16 adult dogs fed diets containing 0% and 9% dried apple for 30 d (n = 8) were evaluated. Finally, Experiment III compared the dietary preference of 0 vs. 9% dried apple using 15 adult dogs. The inclusion of dried apple in the diet (p < 0.05) showed a linear reduction in the ATTD of dry matter (DM), crude protein (CP), and acid hydrolysed ether extract (EEA), and a linear increase in the ATTD of total dietary fibre (TDF). Consumption of 9% of dried apple increased faecal butyrate and reduced propionate and ammonia (p < 0.05). With this diet, there was also an increase (p < 0.05) in the faecal concentration of Faecalibacterium, Erysipelatoclostridium, Blautia, and Bacteroides. No differences were found in the palatability of the diets. The inclusion of up to 9% of dried apple in the diet reduces the digestibility of nutrients and does not influence the dogs' food preference; however, it improves some indicators of dogs' intestinal functionality.


Asunto(s)
Butiratos/metabolismo , Heces/química , Microbioma Gastrointestinal , Malus/química , Alimentación Animal/análisis , Animales , Dieta/veterinaria , Perros , Relación Dosis-Respuesta a Droga , Femenino , Alimentos en Conserva/análisis , Microbioma Gastrointestinal/efectos de los fármacos , Masculino , Distribución Aleatoria
8.
Biomed Pharmacother ; 133: 111012, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33254017

RESUMEN

The beneficial effects of prebiotic, such as fructo-oligosaccharides (FOS), in intestinal inflammation have been demonstrated in several studies. Herein, we evaluate whether joint treatment with FOS, both before and during mucositis, had additional beneficial effects and investigated the mechanisms underlying in the action of FOS on the intestinal barrier. BALB/c mice were randomly divided into five groups: CTR (without mucositis + saline solution), FOS (without mucositis + 6 % FOS), MUC (mucositis + saline solution), PT (mucositis + 6 % FOS supplementation before disease induction), and TT (mucositis + 6 % FOS supplementation before and during disease induction). Mucositis was induced by intraperitoneal injection (300 mg/kg) of 5-fluorouracil (5-FU). After 72 h, the animals were euthanized and intestinal permeability (IP), tight junction, bacterial translocation (BT), histology and morphometry, and immunoglobulin A secretory (sIgA), inflammatory infiltrate, and production of short-chain fatty acids (acetate, butyrate and propionate) were evaluated. The MUC group showed an increase in the IP, BT, and inflammatory infiltrate but a decrease in the tight junction expression and butyrate and propionate levels (P < 0.05). In the PT and TT groups, FOS supplementation maintained the IP, tight junction expression, and propionate concentration within physiologic levels, increased butyrate levels, and reduced BT and inflammatory infiltrate (P < 0.05). Total treatment with FOS (TT group) was more effective in maintaining histological score, morphometric parameters, and sIgA production. Thus, total treatment (prophylactic and therapeutic supplementation) with FOS was more effective than pretreatment alone, in reducing 5-FU-induced damage to the intestinal barrier.


Asunto(s)
Bacterias/efectos de los fármacos , Ácidos Grasos Volátiles/metabolismo , Microbioma Gastrointestinal/efectos de los fármacos , Íleon/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Mucositis/inducido químicamente , Oligosacáridos/farmacología , Prebióticos , Uniones Estrechas/efectos de los fármacos , Acetatos/metabolismo , Animales , Bacterias/metabolismo , Traslocación Bacteriana/efectos de los fármacos , Butiratos/metabolismo , Modelos Animales de Enfermedad , Fluorouracilo , Íleon/metabolismo , Íleon/microbiología , Íleon/patología , Inmunoglobulina A Secretora/metabolismo , Mediadores de Inflamación/metabolismo , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Masculino , Ratones Endogámicos BALB C , Mucositis/metabolismo , Mucositis/microbiología , Mucositis/patología , Permeabilidad , Propionatos/metabolismo , Uniones Estrechas/metabolismo , Uniones Estrechas/microbiología , Uniones Estrechas/patología
10.
Mol Biol Rep ; 47(5): 3919-3928, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32399808

RESUMEN

A functional screening of 1152 clones from a plasmid library constructed with DNA extracted from Brazilian mangrove sediments revealed 3 positive clones for ester-hydrolyzing enzymes, or about one lipolytic gene per 1.2 Mb DNA, which corroborates the idea that oil-contaminated mangroves are a good source of novel microbial lipases/esterases. The partial sequence of the clone LipG7 (1179 bp) showed 30.2% of predicted structure identity with a known esterase, confirming LipG7 as a new member of family VIII esterases. LigG7 shared 80% sequence identity with 1,4-butanediol diacrylate esterase from the Gammaprotebacteria Porticoccus hydrocarbonoclasticus, suggesting it belongs to the Porticoccaceae family. LipG7 was heterologously expressed in Escherichia coli Rosetta-Gami DE3; the purified recombinant enzyme exhibited a predicted molecular weight of 45.2 kDa and exceptional activity towards 4-nitrophenyl butyrate, compared with other recombinant esterases, highlighting its enormous potential for biological applications.


Asunto(s)
Carboxilesterasa/genética , Carboxilesterasa/aislamiento & purificación , Gammaproteobacteria/genética , Secuencia de Aminoácidos/genética , Bacterias/genética , Bacterias/metabolismo , Secuencia de Bases/genética , Brasil , Butiratos/metabolismo , Carboxilesterasa/metabolismo , Esterasas/metabolismo , Gammaproteobacteria/metabolismo , Expresión Génica/genética , Biblioteca de Genes , Metagenoma/genética , Filogenia , Plásmidos/genética , Alineación de Secuencia/métodos , Análisis de Secuencia de ADN/métodos , Especificidad por Sustrato/genética , Humedales
11.
Nutrients ; 12(4)2020 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-32340138

RESUMEN

There is limited information on the effect of black beans (BB) as a source of protein and resistant starch on the intestinal microbiota. The purpose of the present work was to study the effect of cooked black beans with and without high fat and sugar (HF + S) in the diet on body composition, energy expenditure, gut microbiota, short-chain fatty acids, NF-κB, occluding and insulin signaling in a rat model and the area under the curve for glucose, insulin and incretins in healthy subjects. The consumption of BB reduced the percentage of body fat, the area under the curve of glucose, serum leptin, LPS, glucose and insulin concentrations and increased energy expenditure even in the presence of HF + S. These results could be mediated in part by modification of the gut microbiota, by increasing a cluster of bacteria in the Clostridia class, mainly R. bromii, C. eutactus, R. callidus, R. flavefaciens and B. pullicaecorum and by an increase in the concentration of fecal butyrate. In conclusion, the consumption of BB can be recommended to prevent insulin resistance and metabolic endotoxemia by modifying the gut microbiota. Finally, the groups fed BB showed lower abundance of hepatic FMO-3, even with a high-fat diet protecting against the production of TMAO and obesity.


Asunto(s)
Clostridiales , Suplementos Dietéticos , Fabaceae , Microbioma Gastrointestinal , Resistencia a la Insulina , Animales , Distribución de la Grasa Corporal , Butiratos/metabolismo , Endotoxemia/prevención & control , Metabolismo Energético , Glucosa/metabolismo , Voluntarios Sanos , Leptina/metabolismo , Hígado/metabolismo , Masculino , Modelos Animales , Oxigenasas/metabolismo , Ratas Wistar , Espondilitis Anquilosante/microbiología
12.
J Biotechnol ; 316: 6-16, 2020 Jun 10.
Artículo en Inglés | MEDLINE | ID: mdl-32305629

RESUMEN

Feruloyl esterases synthesize butyl hydroxycinnamates, molecules possessing interesting biological properties, nonetheless, they exhibit a low stability under synthesis conditions in organic solvents, restricting its use. To enhance its operational stability in synthesis, we immobilized type A feruloyl esterase from Aspergillus niger (AnFAEA) using several carrier-bound and carrier-free strategies. The most active biocatalysts were: 1) AnFAEA immobilized on epoxy-activated carriers (protein load of 0.6 mgenzyme x mg-1carrier) that recovered 91 % of the initial hydrolytic activity, and 2) AnFAEA aggregated and cross-linked in the presence of 5 mg of BSA and 15 mM of glutaraldehyde (AnFAEA-amino-CLEAs), which exhibited 385 % of its initial hydrolytic activity; both using 4-nitrophenyl butyrate as substrate. The AnFAEA-amino-CLEAs were 12.7 times more thermostable at 60 °C than the AnFAEA immobilized on epoxy-activated carrier, thus AnFAEA-amino-CLEAs were selected for further characterization. Interestingly, during methyl sinapate hydrolysis (pH 7.2 and 30 °C), AnFAEA-amino-CLEAs KM was 15 % higher, while during butyl sinapate synthesis the KM was reduced in 63 %, both compared with the soluble enzyme. The direct esterification of butyl sinapate at solvent free conditions using sinapic acid 50 mM, reached 95 % conversion after 24 h employing AnFAEA-amino-CLEAs, which could be used for 10 cycles without significant activity losses, demonstrating their outstanding operational stability.


Asunto(s)
Aspergillus niger/enzimología , Hidrolasas de Éster Carboxílico/metabolismo , Ácidos Cumáricos/metabolismo , Enzimas Inmovilizadas/metabolismo , Biocatálisis , Butiratos/metabolismo , Hidrolasas de Éster Carboxílico/química , Enzimas Inmovilizadas/química , Glutaral/química , Metacrilatos/química , Polímeros/química , Albúmina Sérica Bovina/química , Dióxido de Silicio/química
13.
Int J Mol Sci ; 20(22)2019 Nov 19.
Artículo en Inglés | MEDLINE | ID: mdl-31752306

RESUMEN

The synthesis of ethyl butyrate catalyzed by lipases A (CALA) or B (CALB) from Candida antarctica immobilized onto magnetic nanoparticles (MNP), CALA-MNP and CALB-MNP, respectively, is hereby reported. MNPs were prepared by co-precipitation, functionalized with 3-aminopropyltriethoxysilane, activated with glutaraldehyde, and then used as support to immobilize either CALA or CALB (immobilization yield: 100 ± 1.2% and 57.6 ± 3.8%; biocatalysts activities: 198.3 ± 2.7 Up-NPB/g and 52.9 ± 1.7 Up-NPB/g for CALA-MNP and CALB-MNP, respectively). X-ray diffraction and Raman spectroscopy analysis indicated the production of a magnetic nanomaterial with a diameter of 13.0 nm, whereas Fourier-transform infrared spectroscopy indicated functionalization, activation and enzyme immobilization. To determine the optimum conditions for the synthesis, a four-variable Central Composite Design (CCD) (biocatalyst content, molar ratio, temperature and time) was performed. Under optimized conditions (1:1, 45 °C and 6 h), it was possible to achieve 99.2 ± 0.3% of conversion for CALA-MNP (10 mg) and 97.5 ± 0.8% for CALB-MNP (12.5 mg), which retained approximately 80% of their activity after 10 consecutive cycles of esterification. Under ultrasonic irradiation, similar conversions were achieved but at 4 h of incubation, demonstrating the efficiency of ultrasound technology in the enzymatic synthesis of esters.


Asunto(s)
Butiratos/metabolismo , Candida/metabolismo , Enzimas Inmovilizadas/química , Enzimas Inmovilizadas/metabolismo , Proteínas Fúngicas/metabolismo , Lipasa/metabolismo , Nanopartículas de Magnetita/química , Biocatálisis , Esterificación/fisiología , Glutaral/metabolismo , Ondas Ultrasónicas
14.
J Agric Food Chem ; 67(42): 11616-11626, 2019 Oct 23.
Artículo en Inglés | MEDLINE | ID: mdl-31542929

RESUMEN

Avocado peel, a byproduct from the avocado pulp industry, is a promising source of polyphenolic compounds. We evaluated the effect of a proanthocyanidin-rich avocado peel polyphenol extract (AvPPE) on the composition and metabolic activity of human fecal microbiota cultured for 24 h in a bioreactor in the presence of high protein (HP) amounts and the effect of the resulting culture supernatants (CSs) on HT-29Glc-/+ and Caco-2 cells. AvPPE decreased the HP-induced production of ammonia, H2S, propionate, and isovalerate and increased that of indole and butyrate. Microbiota composition was marginally affected by HP, whileAvPPE increased the microorganisms/abundance of phylum Actinobacteria, families Coriobacteriaceae and Ruminococcaceae, and genus Faecalibacterium. AvPPE failed to prevent the HP-induced decrease of HT-29Glc-/+ cell viability and energy efficiency but prevented the HP-induced alterations of barrier function in Caco-2 cells. Additionally, the genotoxic effect of the CSs upon HT-29Glc-/+ was attenuated by AvPPE. Therefore, AvPPE may be considered as a promising product for improving colonic homeostasis.


Asunto(s)
Colon/efectos de los fármacos , Homeostasis/efectos de los fármacos , Persea/química , Extractos Vegetales/farmacología , Polifenoles/farmacología , Proantocianidinas/farmacología , Amoníaco/metabolismo , Bacterias/clasificación , Bacterias/genética , Bacterias/aislamiento & purificación , Bacterias/metabolismo , Butiratos/metabolismo , Células CACO-2 , Colon/microbiología , Dieta Rica en Proteínas , Heces/microbiología , Frutas/química , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Proantocianidinas/análisis
15.
FASEB J ; 33(11): 11894-11908, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31366236

RESUMEN

Butyrate is a short-chain fatty acid derived from the metabolism of indigestible carbohydrates by the gut microbiota. Butyrate contributes to gut homeostasis, but it may also control inflammatory responses and host physiology in other tissues. Butyrate inhibits histone deacetylases, thereby affecting gene transcription, and also signals through the metabolite-sensing G protein receptor (GPR)109a. We produced an mAb to mouse GPR109a and found high expression on podocytes in the kidney. Wild-type and Gpr109a-/- mice were induced to develop nephropathy by a single injection of Adriamycin and treated with sodium butyrate or high butyrate-releasing high-amylose maize starch diet. Butyrate improved proteinuria by preserving podocyte at glomerular basement membrane and attenuated glomerulosclerosis and tissue inflammation. This protective phenotype was associated with increased podocyte-related proteins and a normalized pattern of acetylation and methylation at promoter sites of genes essential for podocyte function. We found that GPR109a is expressed by podocytes, and the use of Gpr109a-/- mice showed that the protective effects of butyrate depended on GPR109a expression. A prebiotic diet that releases high amounts of butyrate also proved highly effective for protection against kidney disease. Butyrate and GPR109a play a role in the pathogenesis of kidney disease and provide one of the important molecular connections between diet, the gut microbiota, and kidney disease.-Felizardo, R. J. F., de Almeida, D. C., Pereira, R. L., Watanabe, I. K. M., Doimo, N. T. S., Ribeiro, W. R., Cenedeze, M. A., Hiyane, M. I., Amano, M. T., Braga, T. T., Ferreira, C. M., Parmigiani, R. B., Andrade-Oliveira, V., Volpini, R. A., Vinolo, M. A. R., Mariño, E., Robert, R., Mackay, C. R., Camara, N. O. S. Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms.


Asunto(s)
Butiratos/farmacología , Epigénesis Genética , Microbioma Gastrointestinal/fisiología , Enfermedades Renales/prevención & control , Proteinuria/prevención & control , Receptores Acoplados a Proteínas G/genética , Animales , Bacterias/metabolismo , Butiratos/metabolismo , Células Cultivadas , Masculino , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Podocitos/efectos de los fármacos , Podocitos/metabolismo , Sustancias Protectoras/metabolismo , Sustancias Protectoras/farmacología , Receptores Acoplados a Proteínas G/metabolismo
16.
Bioresour Technol ; 282: 236-244, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30870689

RESUMEN

The aim of this work was to study the metabolic and microbial community dynamics during dark co-fermentation of 80% tequila vinasse and 20% nixtamalization wastewater (w/w). Batch co-fermentations were performed in a 3-L well-mixed reactor at 35 °C and pH 5.5. In correspondence to Illumina MiSeq sequencing and reactor monitoring, changes in metabolites and microbial communities were characterized by three main stages: (i) a first stage during which lactate and acetate producers dominated and consumed the major part of fermentable carbohydrates, (ii) a second stage in which lactate and acetate were consumed by emerging hydrogen-producing bacteria (HPB) in correlation with bioH2 (100 NmL/L-h or 1200 NmL/Lreactor) and butyrate production, and (iii) a third stage during which non-HPB outcompeted HPB after bioH2 production ceased. Altogether, the results of this study suggest that cooperative interactions between lactate producers and lactate- and acetate-consuming HPB could be attributed to lactate- and acetate-based cross-feeding interactions.


Asunto(s)
Ácido Acético/metabolismo , Bebidas Alcohólicas , Fermentación , Hidrógeno/metabolismo , Ácido Láctico/metabolismo , Microbiota , Aguas Residuales/química , Reactores Biológicos/microbiología , Butiratos/metabolismo
17.
Food Res Int ; 118: 81-88, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30898356

RESUMEN

A Mexican staple food prepared with corn "tortilla" (Zea mays L.) and common beans (Phaseolus vulgaris L.) is named as "taco". It was fermented in an in vitro colonic Simulator of Human Microbial Ecosystem (SHIME®) to evaluate the effect in short chain fatty acids (SCFA), ammonia production, and the growth of total presumptive counts for anaerobic bacteria, Lactobacillus spp., Bifidobacterium spp., Clostridium spp., and total coliforms in the three simulated reactors of the human colon. After two weeks of stabilization, the simulator was fed during 9 days with the mixture of 50 g of beans and 50 g of tortilla mixed with 100 mL of carbohydrate based medium. Every third day, samples were collected from the three simulated colon vessels for the corresponding analysis. The production of the SCFA was higher during the treatment period than the basal period in the three colon sections. The acetate was produced in higher concentration (191.9 mmol/L) than propionate and butyrate (29.1 and 55.0 mmol). During the treatment period, the higher molar ratio (%) for acetate, propionate, and butyrate were 84: 14: 24, respectively. The ammonia ions as well as the growth of presumptive coliforms were reduced (p < 0.05) in the three simulated colon vessels during the treatment. Finally, in vitro fermentation of Mexican "taco" showed a possible potential functional profile of an ancestral staple food due to the production of SCFA that may exert beneficial effects.


Asunto(s)
Pan/análisis , Colon/metabolismo , Colon/microbiología , Fabaceae/química , Fermentación , Microbioma Gastrointestinal/fisiología , Zea mays/química , Acetatos/metabolismo , Amoníaco/análisis , Bifidobacterium , Butiratos/metabolismo , Clostridium , Ecosistema , Ácidos Grasos Volátiles/análisis , Bacterias Gramnegativas , Humanos , Lactobacillus , Propionatos/metabolismo
18.
Food Res Int ; 118: 89-95, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30898357

RESUMEN

Mango (Mangifera indica L.) peel (MP), is a by-product from the industrial processing to obtain juices and concentrates, and is rich in polyphenols and dietary fiber (DF). DF content of dried MP is about 40%. The aim of this study was to determine the prebiotic potential of this by-product submitting predigested mango ('Ataulfo') peel to a dynamic in vitro model of the human colon. Dried MPs were predigested following an enzymatic treatment and separating digestion products and undigested material by diafiltration. The predigested samples were fermented in a validated in vitro model of the colon (TIM-2) using human fecal microbiota and sampled after 0, 24, 48 and 72h. A carbohydrate mixture of standard ileal effluent medium (SIEM) was used as control. Production of short chain fatty acids (SCFA), branched chain fatty acids (BCFA) and ammonia profiles were determined in both lumen and dialysates. Microbiota composition was determined by sequencing 16S rRNA gene V3-V4 region. Principal component (PC) analysis of fermentation metabolites and relative abundance of genera was carried out. Fermentation of MP resulted in SCFA concentrations resembling those found in the SIEM experiments, with a 56:19:24 molar ratio for acetic, propionic and butyric acids, respectively. BCFA and ammonia were produced in similar concentrations in both samples. About 80 bacterial genera were identified after fermentation of MP, with an 83% relative abundance of Bifidobacterium at 24h. Three PC were identified; PC1 was influenced by a high Bifidobacterium abundance and low metabolites production. PC2 resulted in a decrease of other genera and an increase of metabolites studied. The relative abundance at 72h in MP was distributed over 4 genera Bifidobacterium, Lactobacillus, Dorea, and Lactococcus. Our results suggest MP as a potential prebiotic ingredient.


Asunto(s)
Colon/microbiología , Digestión , Microbioma Gastrointestinal/fisiología , Mangifera/química , Prebióticos , Adulto , Amoníaco/metabolismo , Bacterias/clasificación , Bacterias/genética , Bifidobacterium/metabolismo , Butiratos/metabolismo , Fibras de la Dieta/análisis , Ácidos Grasos/metabolismo , Ácidos Grasos Volátiles/metabolismo , Heces/microbiología , Femenino , Fermentación , Microbioma Gastrointestinal/genética , Humanos , Lactobacillus , Masculino , ARN Ribosómico 16S/metabolismo
19.
Neotrop Entomol ; 48(1): 18-24, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29417428

RESUMEN

The bronze bug, Thaumastocoris peregrinus Carpintero & Dellapé (Heteroptera: Thaumastocoridae), is an exotic emerging pest in Eucalyptus commercial forests in South America, Africa, and southern Europe. Information on the chemical communication system and reproductive ecology of this insect is scant, and it may be relevant for designing management strategies for eucalypt plantations. Males emit large amounts of 3-methyl-2-butenyl butyrate, which attracts conspecific adult males but not females. To learn more about the biological function of this putative male-produced pheromone, we quantified this compound in volatile emissions collected from males, females, and couples, in three 4-h collecting periods during the morning, afternoon, and night of a single 24-h cycle. Our results showed that virgin males emit 3-methyl-2-butenyl butyrate in a diel time pattern, with an almost sevenfold difference between the afternoon emission peak compared to morning or night hours. In addition, we show that in the presence of females, males emit the compound in the same amounts throughout the photocycle. While a definite function cannot yet be attributed to the emission of 3-methyl-2-butenyl butyrate by T. peregrinus males, our findings point to an intraspecific function, possibly one related to male-male competition.


Asunto(s)
Butiratos/metabolismo , Heterópteros/fisiología , Periodicidad , Feromonas/biosíntesis , Animales , Femenino , Masculino , Compuestos Orgánicos Volátiles/metabolismo
20.
Appl Microbiol Biotechnol ; 102(20): 8827-8840, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30121748

RESUMEN

This study aimed to evaluate the effects of three treatments, i.e., Bifidobacterium longum BB-46 (T1), B. longum BB-46 combined with the pectin (T2), and harsh extracted pectin from lemon (T3) on obesity-related microbiota using the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). The effects of the treatments were assessed by the analysis of the intestinal microbial composition (using 16S rRNA gene amplicon sequencing) and the levels of short-chain fatty acids (SCFAs) and ammonium ions (NH4+). Treatments T2 and T3 stimulated members of the Ruminococcaceae and Succinivibrionaceae families, which were positively correlated with an increase in butyric and acetic acids. Proteolytic bacteria were reduced by the two treatments, concurrently with a decrease in NH4+. Treatment T1 stimulated the production of butyric acid in the simulated transverse and descending colon, reduction of NH4+ as well as the growth of genera Lactobacillus, Megamonas, and members of Lachnospiracea. The results indicate that both B. longum BB-46 and pectin can modulate the obesity-related microbiota; however, when the pectin is combined with B. longum BB-46, the predominant effect of the pectin can be observed. This study showed that the citric pectin is able to stimulate butyrate-producing bacteria as well as genera related with anti-inflammatory effects. However, prospective clinical studies are necessary to evaluate the anti/pro-obesogenic and inflammatory effects of this pectin for future prevention of obesity.


Asunto(s)
Bacterias/aislamiento & purificación , Bifidobacterium longum/fisiología , Microbioma Gastrointestinal , Obesidad/microbiología , Pectinas/metabolismo , Probióticos/administración & dosificación , Bacterias/clasificación , Bacterias/genética , Bacterias/metabolismo , Butiratos/metabolismo , Ácidos Grasos Volátiles , Heces/microbiología , Fermentación , Humanos , Mucosa Intestinal/metabolismo , Intestinos/microbiología , Obesidad/tratamiento farmacológico , Obesidad/metabolismo , Filogenia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA